Overall, the data suggest a complex interplay of type 2 cytokines in COVID-19 severity, though little is known about IL-4, as distinct from IL-13, or the kinetics of the 2 cytokines effects in the context of early viremia and longer inflammatory processes. This evidence concerns the gene IL4 and COVID-19.